BGI Genomics Co Ltd (300676) — Cash Flow-to-Debt Ratio
BGI Genomics Co Ltd (300676) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-3.08 Million could theoretically repay 0% of its total liabilities (CN¥2.93 Billion) in one year. Explore 300676 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BGI Genomics Co Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for BGI Genomics Co Ltd across 14 annual periods. Also explore how large is BGI Genomics Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for BGI Genomics Co Ltd (2012–2025)
Year-by-year debt coverage analysis for BGI Genomics Co Ltd. For market capitalisation and broader financial context, see 300676 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.02x | CN¥-63.21 Million | CN¥3.14 Billion | ▼ -168.8% |
| 2024 | 0.03x | CN¥95.72 Million | CN¥3.27 Billion | ▼ -74.2% |
| 2023 | 0.11x | CN¥408.77 Million | CN¥3.61 Billion | ▲ +260.3% |
| 2022 | 0.03x | CN¥130.88 Million | CN¥4.16 Billion | ▼ -93.9% |
| 2021 | 0.51x | CN¥2.48 Billion | CN¥4.81 Billion | ▼ -24.0% |
| 2020 | 0.68x | CN¥3.60 Billion | CN¥5.32 Billion | ▲ +357.7% |
| 2019 | 0.15x | CN¥224.25 Million | CN¥1.52 Billion | ▲ +908.7% |
| 2018 | 0.01x | CN¥14.69 Million | CN¥1.00 Billion | ▼ -94.9% |
| 2017 | 0.29x | CN¥243.66 Million | CN¥853.88 Million | ▼ -5.2% |
| 2016 | 0.30x | CN¥234.07 Million | CN¥777.52 Million | ▼ -32.1% |
| 2015 | 0.44x | CN¥328.68 Million | CN¥741.37 Million | ▲ +3268.0% |
| 2014 | -0.01x | CN¥-8.16 Million | CN¥583.40 Million | ▼ -134.3% |
| 2013 | 0.04x | CN¥36.70 Million | CN¥899.46 Million | ▼ -52.0% |
| 2012 | 0.08x | CN¥72.49 Million | CN¥853.31 Million | — |